NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Block, Inc. (NYSE:XYZ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/block-inc-lawsuit-submission-form-2?prid=128719&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128720&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128721&wire=1 or contact Joseph E. Levi, Esq.

Paris, France--(Newsfile Corp. - February 11, 2025) - Sequans Communications S.A. (NYSE: SQNS) ("Sequans" or the "Company"), a leading developer and provider of 5G/4G semiconductors and IoT modules, today announced preliminary financial results for the fourth quarter and full year ended December 31, 2024.

Fourth quarter reported net sales up 0.5% YOY; Organic sales up 2.4% YOY and 1.7% sequentially Fourth quarter diluted EPS of $3.03; Adjusted diluted EPS of $3.16, up 19% YOY Full-year reported net sales down 2.5% YOY; Organic sales down 0.6% YOY Full-year operating profit of $1.2 billion; operating margin of 5.6% Adjusted EBITDA margin of 6.9%, down 70 basis points YOY Record operating cash flow of $1.1 billion for 2024, up from $493 million for 2023 PITTSBURGH , Feb. 11, 2025 /PRNewswire/ -- Wesco International (NYSE: WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, …

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128722&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128724&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128726&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerning possible violations of federal securities laws. Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud".

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (“Q1 Fiscal 2025”). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill.

SAN JOSE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the company whose innovations shape the way the world explores and experiences entertainment, today announced that Fetch TV, an Australian digital entertainment platform, has renewed a multi-year agreement to license Adeia's media intellectual property (IP) portfolio.

Cleveland-Cliffs (CLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Does the past provide clues about what the future holds? Sometimes it does.

SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in automotive lidar technology, today announced that it will deepen its cooperation with BYD and will provide automotive lidar for more than 10 BYD models. The models are expected to enter mass production in 2025.

Uber: Strong Bookings Today, Tremendous AV Opportunity Tomorrow

Permitted CK Gold Project shows compelling economic indicators (Company webinar Tuesday February 11 th, 2025, at 11:00am EST) CHEYENNE, Wyo., Feb. 11, 2025 /PRNewswire/ -- U.S. Gold Corp. ("U.S. Gold," the "Company," "we," "our" or "us") (NASDAQ: USAU), is pleased to announce the results of its updated pre-feasibility study ("PFS") for its CK Gold Project ("CK", or "CK Gold") in Wyoming, U.S.A.

PITTSBURGH, Feb. 11, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc.

The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog.

LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily Oral Rinse Multicenter Phase 2a Trial Advancing to Higher Treatment Dose with Recruitment Expected to Conclude the First Half of 2025 Lipella Leadership to Present Findings at BIO CEO & Investor Conference on Tuesday, February 11, 2025, at 2:30 p.m. EST PITTSBURGH, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today shared topline analysis of its …

Tesla (NASDAQ: TSLA) released its Q4 and full-year 2024 earnings report on January 29, with it marking the first time the automaker saw a year-over-year (YoY) decline in vehicle deliveries.